跳至主要内容
临床试验/EUCTR2007-003767-51-GB
EUCTR2007-003767-51-GB进行中(未招募)不适用

Vitamin D therapy to reduce cardiovascular risk in Type 2 diabetes – the next steps

Research and Innovation Services, University of Dundee0 个研究点开始时间: 2007年11月26日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Diagnosis of type 2 diabetes mellitus
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Taking vitamin D supplements
  • - Serum 25 hydroxy vitamin D level of >100nmolL
  • - Serum creatinine >200umol/l
  • - Liver function tests >3 times the upper limit of normal
  • - Hyper or hypocalcaemia (corrected calcium >2.55 or <2.15mmol/l, respectively)
  • - History of sarcoidosis
  • - History of renal calculi
  • - Metastatic malignancy
  • - Inability to give informed consent.

研究者

发起方
Research and Innovation Services, University of Dundee

相似试验

Vitamin D therapy to reduce cardiovascular risk in... | 临床试验